Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Akoya Biosciences initiated with an Overweight at JPMorgan » 07:09
05/11/21
05/11
07:09
05/11/21
07:09
AKYA

Akoya Biosciences

$19.19 /

-0.86 (-4.29%)

JPMorgan analyst Tycho…

JPMorgan analyst Tycho Peterson initiated coverage of Akoya Biosciences with an Overweight rating and $23 price target. Akoya is a leader in spatial phenotyping technology with a "comprehensive end-to-end portfolio," Peterson tells investors in a research note. With a "large" $17B total address market for spatial biology, the company is well positioned to execute and deliver attractive revenue growth and margin expansion, says the analyst.

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

05/11/21 Morgan Stanley
Morgan Stanley starts Akoya Biosciences at Overweight with $26 price target
05/11/21 Morgan Stanley
Akoya Biosciences initiated with an Overweight at Morgan Stanley
05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
  • 16
    Apr
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

Initiation
Morgan Stanley starts Akoya Biosciences at Overweight with $26 price target » 06:59
05/11/21
05/11
06:59
05/11/21
06:59
AKYA

Akoya Biosciences

$19.19 /

-0.86 (-4.29%)

As previously reported,…

As previously reported, Morgan Stanley analyst Tejas Savant initiated coverage of Akoya Biosciences with an Overweight rating and $26 price target. Akoya is a spatial biology company whose solutions "compare favorably" to both legacy and next gen platforms, argues Savant, who forecasts the company to have a top-line compound annual growth rate of greater than 30% through 2024.

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

05/11/21 Morgan Stanley
Akoya Biosciences initiated with an Overweight at Morgan Stanley
05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
  • 16
    Apr
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

Initiation
Akoya Biosciences initiated with an Overweight at Morgan Stanley » 06:00
05/11/21
05/11
06:00
05/11/21
06:00
AKYA

Akoya Biosciences

$19.19 /

-0.86 (-4.29%)

Morgan Stanley analyst…

Morgan Stanley analyst Tejas Savant initiated coverage of Akoya Biosciences with an Overweight rating and $26 price target.

ShowHide Related Items >><<
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

05/11/21 Piper Sandler
Akoya Biosciences initiated with an Overweight at Piper Sandler
  • 16
    Apr
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

Initiation
Akoya Biosciences initiated with an Overweight at Piper Sandler » 04:54
05/11/21
05/11
04:54
05/11/21
04:54
AKYA

Akoya Biosciences

$19.19 /

-0.86 (-4.29%)

Piper Sandler analyst…

Piper Sandler analyst Steven Mah initiated coverage of Akoya Biosciences with an Overweight rating and $28 price target. Akoya is a leading global player in the emerging field of spatial biology, Mah tells investors in a research note. The analyst believes Akoya's technology will generate additional discoveries that will grow the current market from $17B through additional applications across biology. He thinks spatial biology is in "early-innings with strong growth drivers" in discovery, translational and clinical applications.

ShowHide Related Items >><<
  • 16
    Apr
AKYA Akoya Biosciences
$19.19 /

-0.86 (-4.29%)

Over a week ago
On The Fly
Opening Day: Coinbase soars in market debut » 09:03
04/17/21
04/17
09:03
04/17/21
09:03
RXRX

Recursion Pharmaceuticals

$31.06 /

+0.81 (+2.68%)

, BMEA

Biomea Fusion

$18.48 /

-1.92 (-9.41%)

, AKYA

Akoya Biosciences

$26.92 /

+0.18 (+0.67%)

, APP

AppLovin

$61.01 /

-3.795 (-5.86%)

, AGL

Agilon Health

$30.45 /

-0.43 (-1.39%)

, KRT

Karat Packaging

$18.38 /

-0.52 (-2.75%)

, TSP

TuSimple

$39.99 /

+0.53 (+1.34%)

, EBET

Esports Technologies

$25.35 /

-10.69 (-29.66%)

, COIN

Coinbase

$341.27 /

+15.78 (+4.85%)

, ALKT

Alkami

$42.13 /

-0.13 (-0.31%)

, SQSP

Squarespace

/

+

, SVFD

Save Foods

/

+

, RGCB

Regencell Bioscience

/

+

, SWIM

Latham Group

/

+

, EDR

Endeavor

$41.49 /

+ (+0.00%)

, UBER

Uber

$60.34 /

-0.405 (-0.67%)

, LYFT

Lyft

$63.36 /

-1.07 (-1.66%)

Shares of Coinbase jumped…

ShowHide Related Items >><<
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

RXRX Recursion Pharmaceuticals
$31.06 /

+0.81 (+2.68%)

BMEA Biomea Fusion
$18.48 /

-1.92 (-9.41%)

AKYA Akoya Biosciences
$26.92 /

+0.18 (+0.67%)

APP AppLovin
$61.01 /

-3.795 (-5.86%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

KRT Karat Packaging
$18.38 /

-0.52 (-2.75%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

04/15/21 Loop Capital
Loop Capital starts Coinbase at Buy, sees 'lots of runway before takeoff'
04/15/21 Loop Capital
Coinbase initiated with a Buy at Loop Capital
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 DA Davidson
Coinbase price target raised to $650 from $440 at DA Davidson
ALKT Alkami
$42.13 /

-0.13 (-0.31%)

SQSP Squarespace
/

+

SVFD Save Foods
/

+

RGCB Regencell Bioscience
/

+

SWIM Latham Group
/

+

EDR Endeavor
$41.49 /

+ (+0.00%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
LYFT Lyft
$63.36 /

-1.07 (-1.66%)

04/05/21 Evercore ISI
Lyft assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Lyft assumed with a Peer Perform at Wolfe Research
03/26/21
Fly Intel: Top five analyst initiations
03/26/21 Vertical Research
Lyft initiated with a Buy at Vertical Research
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

  • 23
    Apr
  • 14
    Apr
  • 15
    Apr
  • 16
    Apr
  • 16
    Apr
  • 16
    Apr
  • 15
    Apr
  • 15
    Apr
  • 15
    Apr
  • 14
    Apr
  • 15
    Apr
  • 08
    Jan
UBER Uber
$60.34 /

-0.405 (-0.67%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

SQSP Squarespace
/

+

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

Syndicate
Akoya Biosciences opens at $26, IPO priced at $20 per share  12:10
04/16/21
04/16
12:10
04/16/21
12:10
AKYA

Akoya Biosciences

/

+

 
ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Akoya Biosciences indicated to open at $25, IPO priced at $20  11:04
04/16/21
04/16
11:04
04/16/21
11:04
AKYA

Akoya Biosciences

/

+

 
ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Akoya Biosciences indicated to open at $20.15, IPO priced at $20.00 » 10:49
04/16/21
04/16
10:49
04/16/21
10:49
AKYA

Akoya Biosciences

/

+

Akoya Biosciences (AKYA)…

Akoya Biosciences (AKYA) priced 6.58M shares at $20.00, at the high-end of the $18.00-$20.00 range. JPMorgan, Morgan Stanley, Piper Sandler and Canaccord acted as joint book running managers for the offering.

ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Akoya Biosciences 6.58M share IPO priced at $20.00 » 06:30
04/16/21
04/16
06:30
04/16/21
06:30
AKYA

Akoya Biosciences

/

+

The deal priced at the…

The deal priced at the high-end of the $18.00-$20.00 range. JPMorgan, Morgan Stanley, Piper Sandler and Canaccord acted as joint book running managers for the offering.

ShowHide Related Items >><<
  • 16
    Apr
Syndicate
Akoya Biosciences 6.58M share IPO price range $18.00-$20.00 » 10:44
04/12/21
04/12
10:44
04/12/21
10:44
AKYA

Akoya Biosciences

/

+

JPMorgan, Morgan Stanley,…

JPMorgan, Morgan Stanley, Piper Sandler and Canaccord are acting as joint book running managers for the offering.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.